Updates are available Correction dated 2020-06-08
Click to view Correction: https://doi.org/10.1007/s10620-020-06374-4
-
Authors
Abell, Thomas L. https://orcid.org/0000-0002-3175-5161
Kedar, Archana
Stocker, Abigail
Beatty, Karen
McElmurray, Lindsay
Hughes, Michael
Rashed, Hani
Kennedy, William
Wendelschafer-Crabb, Gwen
Yang, Xiu
Fraig, Mostafa
Gobejishvili, Leila
Omer, Endashaw
Miller, Ed
Griswold, Michael
Pinkston, Christina
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03178370 at ClinicalTrials.govDocuments that mention this clinical trial
Pathophysiology of Gastroparesis Syndromes Includes Anatomic and Physiologic Abnormalities
https://doi.org/10.1007/s10620-020-06259-6
-
Funding
Funding for this research was provided by:
NIH Diabetes Complication Consortium (U24DK076169)
- License Information
-
More Information
Article History
Received: 14 May 2019
Accepted: 8 April 2020
First Online: 23 April 2020
Change Date: 8 June 2020
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10620-020-06374-4
Compliance with Ethical Standards
:
: Dr. Abell has been an investigator for Medtronic, Rhythm, Theravance, Vanda and Allergan, and has been a consultant for Theravance, Censa and Nuvaira. He is the GI Section Editor for Med Study, GI Stimulation editor for <i>Neuromodulation</i>, GES editor for Wikistim, and a reviewer for UpToDate. Dr. Abell is the founder of ADEPT-GI, which holds intellectual property covering some aspects of technology in this manuscript. There are no other disclosures.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
